3280-F5 EXECUTIVE OFFICE OF THE PRESIDENT Office of ...
This document is scheduled to be published in the Federal Register on 08/22/2017 and available online at https://federalregister.gov/d/2017-17689, and on FDsys.gov
3280-F5
EXECUTIVE OFFICE OF THE PRESIDENT Office of National Drug Control Policy Appointment of Members of Senior Executive Service Performance Review Board AGENCY:
Office of National Drug Control Policy (ONDCP)
ACTION:
Notice of Appointments.
SUMMARY: The following persons have been appointed to the ONDCP Senior Executive Service Performance Review Board: Dr. Terry Zobeck (as Chair), Mr. Michael Gottlieb, Ms. Michele Marx, and Mr. Kemp Chester. FOR FURTHER INFORMATION CONTACT: Please direct any questions to Michael Passante, Deputy General Counsel (202) 395-6709, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503.
Dated: August 16, 2017
Michael Passante Deputy General Counsel
[FR Doc. 2017-17689 Filed: 8/21/2017 8:45 am; Publication Date: 8/22/2017]
1
3280-F5
EXECUTIVE OFFICE OF THE PRESIDENT Office of National Drug Control Policy Appointment of Members of Senior Executive Service Performance Review Board AGENCY:
Office of National Drug Control Policy (ONDCP)
ACTION:
Notice of Appointments.
SUMMARY: The following persons have been appointed to the ONDCP Senior Executive Service Performance Review Board: Dr. Terry Zobeck (as Chair), Mr. Michael Gottlieb, Ms. Michele Marx, and Mr. Kemp Chester. FOR FURTHER INFORMATION CONTACT: Please direct any questions to Michael Passante, Deputy General Counsel (202) 395-6709, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503.
Dated: August 16, 2017
Michael Passante Deputy General Counsel
[FR Doc. 2017-17689 Filed: 8/21/2017 8:45 am; Publication Date: 8/22/2017]
1
